Centenial Surgical Suture discloses AGM voting results and scrutinizer report

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • All three resolutions passed with over 99.99% majority support
  • Promoter group voted 100% of their 17,10,601 shares on key items
  • Public non-institutional shareholders voted on only 41.82% of holdings
  • Scrutinizer Hemant Shetye of HSPN & Associates LLP certified results
powered bylight_fuzz_icon
52156690

*this image is generated using AI for illustrative purposes only.

Centenial Surgical Suture Ltd has disclosed the detailed voting results and the scrutinizer's report for its 31st Annual General Meeting (e-AGM) held on September 28, 2026. The filing confirms that all three proposed resolutions passed with a clear majority, adhering to SEBI (LODR) Regulations, 2015.

The meeting, conducted via video conferencing from 2:00 pm to 2:25 pm, was chaired by Vijay Majrekar. A total of 25 shareholders participated virtually, comprising three from the promoter group and 22 public shareholders. The record date for determining voting entitlements was September 21, 2026. The scrutinizer appointed for the process was Hemant Shetye of HSPN & Associates LLP.

Key Resolutions Passed

Shareholders voted on three ordinary resolutions. The first resolution involved receiving, considering, and adopting the audited financial statements for the financial year ended March 31, 2026, along with the reports of the Board of Directors and Auditors. This resolution received overwhelming support, with 99.99% of valid votes cast in favor.

The second and third resolutions pertained to the appointment and reappointment of Anuradha Kashikar as Executive Director. She retired by rotation and offered herself for reappointment. Both resolutions passed with similar margins of support.

Resolution Item Description Votes in Favour (%) Votes Against (%) Status
Item 1 Adoption of Audited Accounts FY26 99.99% 0.01% Passed
Item 2 Appointment of Director (Rotation) 99.99% 0.01% Passed
Item 3 Re-appointment of Executive Director 99.99% 0.01% Passed

Voting Participation Details

The voting process was facilitated through remote e-voting via Purva Sharegistry India Private Limited, which remained open from September 24 to September 27, 2026. Additionally, live e-voting was available during the meeting for attendees who had not previously cast their votes.

For Items 1 and 2, a total of 25,20,942 votes were polled out of the total outstanding shares. Only one vote was recorded against these resolutions. For Item 3, which concerned the specific reappointment of Ms. Kashikar, her own votes were treated as invalid due to interest in the resolution. Consequently, the total valid votes polled for this item stood at 18,22,442, with 6,98,500 votes classified as invalid.

What the Numbers Show

The voting data reveals a high concentration of promoter participation relative to public engagement. Promoters and their group held 17,10,601 shares and cast all their votes for Items 1 and 2, contributing significantly to the total poll. In contrast, public non-institutional shareholders, holding 19,37,699 shares, only exercised voting rights on 41.82% of their holdings for the same items. This divergence highlights that while the resolutions passed unanimously in spirit, active shareholder engagement from the public segment remains limited compared to the promoter group's full participation.

Historical Stock Returns for Centenial Surgical Suture

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%+3.86%+7.44%+27.08%-4.90%0.0%

How might the low public shareholder participation rate of 41.82% impact Centenial Surgical Suture's future corporate governance ratings and investor confidence?

What strategic initiatives is Executive Director Anuradha Kashikar expected to prioritize in the upcoming fiscal year following her reappointment with overwhelming support?

Given the high promoter voting concentration, are there any anticipated changes to the company's dividend policy or capital allocation strategy for FY27?

Centenial Surgical Suture
View Company Insights
View All News
like20
dislike

Centenial Surgical Suture schedules 31st AGM on September 28, 2026

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Centenial Surgical Suture Ltd has scheduled its 31st e-AGM via video conferencing on September 28, 2026, at 2:00 pm
  • Members will vote on adoption of audited accounts for the year ended March 31, 2026
  • Re-appointment of Executive Director Anuradha Kashikar (DIN: 00804831) for three years from April 1, 2027 to March 31, 2030 with NIL remuneration is on the agenda
  • Remote e-voting opens September 24, 2026 at 9:00 am and closes September 27, 2026 at 5:00 pm; cut-off date is September 21, 2026
  • Anuradha Kashikar holds 6,98,500 equity shares and is the spouse of Managing Director Vijay Majrekar
powered bylight_fuzz_icon
49822563

*this image is generated using AI for illustrative purposes only.

Centenial Surgical Suture Ltd has scheduled its 31st Annual General Meeting (e-AGM) via video conferencing on Monday, September 28, 2026, at 2:00 pm, to transact ordinary and special business for FY26.

Key agenda items

The meeting will cover two categories of business. Under ordinary business, members will consider adopting the audited accounts for the year ended March 31, 2026, and the re-appointment of Anuradha Kashikar, Executive Director (DIN: 00804831), who retires by rotation. Under special business, members will vote on her re-appointment as Executive Director for a further term of three years from April 1, 2027 to March 31, 2030, with NIL remuneration.

Agenda item Details
Meeting date September 28, 2026
Meeting mode Video conferencing / other audio-visual means
Adoption of accounts Audited accounts for year ended March 31, 2026
Director retiring by rotation Anuradha Kashikar, Executive Director (DIN: 00804831)
Re-appointment tenure April 1, 2027 to March 31, 2030 (three years)
Remuneration NIL

Director profile: Anuradha Kashikar

Anuradha Kashikar, aged 65 years, holds a Bachelor of Commerce (B.Com) and a Bachelor of Law (LLB) from the University of Mumbai. She has served as Executive Director and Chief Financial Officer of the company since March 27, 2015, and is primarily responsible for managing the financial risks of the company as well as financial planning and record-keeping. She holds 6,98,500 equity shares in the company. She is the spouse of Vijay Majrekar, Managing Director of the company. Her current term expires on March 31, 2027.

The Board of Directors, at its meeting held on August 14, 2026, approved her re-appointment based on the recommendation of the Nomination and Remuneration Committee, subject to shareholder approval at the 31st AGM.

E-voting and record date

The company has engaged Purva Shareregistry (India) Private Limited as the authorised e-voting agency. Key dates for the e-voting process are as follows:

Event Date / Time
Cut-off date for voting eligibility September 21, 2026
Register of Members closure (start) September 22, 2026
Register of Members closure (end) September 28, 2026
Remote e-voting opens September 24, 2026, 9:00 am
Remote e-voting closes September 27, 2026, 5:00 pm
AGM date September 28, 2026, 2:00 pm

Members holding shares as of the cut-off date of September 21, 2026 are eligible to vote. The VC facility will be available to at least 1,000 members on a first-come-first-served basis, excluding large shareholders holding 2% or more, promoters, institutional investors, directors, and key managerial personnel, who may attend without restriction.

Access and participation

The notice of the 31st e-AGM and the Integrated Annual Report for FY26 are being sent electronically to members whose email addresses are registered with the company or depositories, in accordance with the relevant MCA and SEBI circulars. Members who wish to obtain a physical copy of the Annual Report may write to the company at shareinvestor@centenialindia.com . The AGM notice is also available on the company's website and on the BSE Limited website.

Historical Stock Returns for Centenial Surgical Suture

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%+3.86%+7.44%+27.08%-4.90%0.0%

How might the re-appointment of Anuradha Kashikar with NIL remuneration signal the company's stance on executive compensation and shareholder value alignment?

What specific financial performance metrics in the FY26 audited accounts are investors most likely to scrutinize given the upcoming leadership continuity?

Could the continued tenure of the Executive Director until 2030 impact Centenial Surgical's strategic roadmap for product innovation or market expansion?

Centenial Surgical Suture
View Company Insights
View All News
like15
dislike

More News on Centenial Surgical Suture

1 Year Returns:-4.90%